The Textbook of Pharmaceutical Medicine

This book has grown considerably since the first edition in 1993. The fifth edition is the most comprehensive of all editions to date and reflects the increasing complexity of the speciality. The enthusiastic uptake of this book is a tribute to the Faculty of Pharmaceutical Medicine of The Royal Colleges of Physicians of the United Kingdom who have done so much to sponsor the discipline leading to the achieving the status of specialist recognition. However, we have been aware that the book has appealed to a mush wider audience than those for whom it was initially written, namely those studying for the Diploma of Pharmaceutical Medicine. it is now the standard text used by courses in pharmaceutical medicine in both Europe and the United States. Widening the scope of the textbook to cover all aspects of the speciality's Higher Medical Training (HMT) programme has also increased the usefulness of the book to those working in National Dug Regulatory Authorities, as well as those involved in the economics of healthcare, pharmaceutical marketing and NHS purchasing of medical products. * Iatrogenic Diseases * A Manual of Adverse * The Textbook of Pharmaceutical Medicine * Medicines, Research, Regulation and Risk From 1991 to 2003 he served as Editor in Chief of Adverse Drug Reactions and Toxicological Reviews, a peer-reviewed journal produced quarterly by Oxford University Press. Professor John O Grady, MD, FRCP, EEPM, FBIRA, MRCPath, after graduating in medicine, trained in general medicine and also in clinical pharmaceutical and therapeutics to achieve specialist registrations. He held medical appointments at the Radcliffe Infirmary in Oxford, Royal Postgraduate Medical School, Hammersmith Hospital for Nervous Diseases Queen`s Square, London and St Bartholomew`s Hospital London. Formerly Head of clinical Pharmacology at Welcome Research Laboratories, then Medical Director Rhone-Poulenc and Visiting Professor at the University of Cape Town, South Africa. Professor O Grady is examiner of the Royal College of Physicians, Faculty of Pharmaceutical Medicine. He is a fellow of the Royal Statistical Society and Visiting Professor of Clinical Pharmacology, University of London. He has published widely in the field of medicine, in clinical pharmaceutical and therapeutics and in pharmaceutical medicine. He is editor of several books dealing with drug effects in man and with medicines and the law. Table of Contents * Part I: Research and development * Part II: Medical department issues * Part III: Regulatory aspects * Part IV: Pharmacoeconomic and other issues